No results for ‘’
Roselabs Finance Ltd
NSE: BSE: 531324
â‚ą22.03
(4.96%)
Wed, 16 Sept 2026, 02:19 am
Market Cap (in Cr)22.09
PE Ratio0
Dividend0
Finance
Real Estate Development
24.5KRoselabs Finance Analysis
dividend
- Unable to evaluate Roselabs Finance's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Roselabs Finance's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Roselabs Finance has no long term commitments.
- Low level of unsold assets.
- Roselabs Finance's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Roselabs Finance has less than a year of cash runway based on current free cash flow.
- Operating cash flow is negative therefore debt is not well covered.
- Roselabs Finance has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
- Irrelevant to check if Roselabs Finance's debt level has increased considering it has negative shareholder equity.
- Roselabs Finance has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
management
- The average tenure for the Roselabs Finance board of directors is less than 3 years, this suggests a new board.
misc
- Roselabs Finance is not covered by any analysts.
- BSE:531324 has not traded for 89 days.
past
- Unable to compare Roselabs Finance's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Roselabs Finance does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Roselabs Finance has efficiently used its assets last year compared to the IN Diversified Financial industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Roselabs Finance improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
- It is difficult to establish if Roselabs Finance has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
- Unable to compare Roselabs Finance's 1-year growth to the IN Diversified Financial industry average as it is not currently profitable.
value
- BSE:531324 is flat (0%) outperforming the Diversified Financial industry which returned -7.8% over the past month.
- BSE:531324 is flat (0%) along with the India market (-0.3%) over the past month.
- Roselabs Finance has negative assets, we can't compare the value of its assets to the IN Diversified Financial industry average.
- Roselabs Finance is loss making, we can't compare its value to the IN Diversified Financial industry average.
- Roselabs Finance is loss making, we can't compare the value of its earnings to the India market.